A prospective study of platelet derived microparticles in pediatric patients with coagulopathy afer hematopoietic stem cell transplantation.

A prospective study of platelet derived microparticles in pediatric patients with coagulopathy afer hematopoietic stem cell transplantation. - A study of platelet derived microparticles in pediatric patients afer hematopoietic stem cell transplantation.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026864

Enrollment

Registered

2017-04-05

Start date

2017-04-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatirc hematopoietic stem cell tranaplantaion

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing hematopoietic stem cell transplantation at Hospital of University of the Ryukyus (in- and out-patients) from April 2017 to March 2020. 2. Age of 0-18 years.

Exclusion criteria

Exclusion criteria: 1. Patients having serious coagulopathy such as DIC at transplantation. 2. Patients who refuse to participate in this study.

Design outcomes

Primary

Measure	Time frame
Evaluation of PDMP : pre-transplant, post-transplant at week1, week2, week3, week4, 2 months, 3 months	—

Secondary

Measure	Time frame
1. Evaluation of solulble P-selectin, solulble E-selectin, solulble VCAM-1 and solulble ICAM-1: pre-transplant, post-transplant at week1, week2, week3, week4, 2 months, 3 months 2. Transplant prognosis.	—

Countries

Japan

Contacts

Public ContactNobuyuki Hyakuna

Hospital of University of the Ryukyus Pediatrics

hyakunan@med.u-ryukyu.ac.jp098-895-3331

Outcome results